Davies, Melanie J.

Liraglutide and cardiovascular outcomes in adults with overweight or obesity: A post hoc analysis from SCALE randomized controlled trials

Davies, M. J., Aronne, L. J., Caterson, I. D., Thomsen, A. B., Jacobsen, P. B., Marso, S. P., & groups, O. B. O. T. S. A. C. A. –. L. E. I. I. W. A. W. D. (. S. (2018) · Diabetes, Obesity and Metabolism

Pharmacology and Obesity TreatmentDiabetes Treatment and Management

Cited by 115

Effects of once-weekly semaglutide 2.4 mg on C-reactive protein in adults with overweight or obesity (STEP 1, 2, and 3): exploratory analyses of three randomised, double-blind, placebo-controlled, phase 3 trials

Verma, S., Bhatta, M., Davies, M., Deanfield, J. E., Garvey, W. T., Jensen, C., Kandler, K., Kushner, R. F., Rubino, D. M., & Kosiborod, M. N. (2023) · eClinicalMedicine

Adipokines, Inflammation, and Metabolic DiseasesPharmacology and Obesity Treatment

Cited by 106

Associations of mutually exclusive categories of physical activity and sedentary time with markers of cardiometabolic health in English adults: a cross-sectional analysis of the Health Survey for England

Bakrania, K., Edwardson, C. L., Bodicoat, D. H., Esliger, D. W., Gill, J. M. R., Kazi, A., Velayudhan, L., Sinclair, A. J., Sattar, N., Biddle, S. J. H., et al. (2015) · BMC Public Health

Physical Activity and HealthObesity, Physical Activity, Diet

Cited by 106

Effects of semaglutide on symptoms, function, and quality of life in patients with heart failure with preserved ejection fraction and obesity: a prespecified analysis of the STEP-HFpEF trial

Kosiborod, M. N., Verma, S., Borlaug, B. A., Butler, J., Davies, M. J., Jon Jensen, T., Rasmussen, S., Erlang Marstrand, P., Petrie, M. C., Shah, S. J., et al. (2024) · Circulation

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 104

Effectiveness of therapeutic patient education interventions for chronic diseases: A systematic review and meta-analyses of randomized controlled trials

Correia, J. C., Waqas, A., Assal, J.-P., Davies, M. J., Somers, F., Golay, A., & Pataky, Z. (2023) · Frontiers in Medicine

Diabetes Management and EducationChronic Disease Management Strategies

Cited by 104

Acknowledging and allocating responsibility for clinical inertia in the management of Type 2 diabetes in primary care: a qualitative study

Zafar, A., Stone, M. A., Davies, M. J., & Khunti, K. (2015) · Diabetic Medicine

Diabetes Management and EducationDiabetes Treatment and Management

Cited by 103

Incretins and microvascular complications of diabetes: neuropathy, nephropathy, retinopathy and microangiopathy

Goldney, J., Sargeant, J. A., & Davies, M. J. (2023) · Diabetologia

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 100

Effects of semaglutide on albuminuria and kidney function in people with overweight or obesity with or without type 2 diabetes: exploratory analysis from the STEP 1, 2, and 3 trials

Heerspink, H. J. L., Apperloo, E., Davies, M., Dicker, D., Kandler, K., Rosenstock, J., Sørrig, R., Lawson, J., Zeuthen, N., & Cherney, D. (2023) · Diabetes Care

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 98

Design and Baseline Characteristics of STEP-HFpEF Program Evaluating Semaglutide in Patients With Obesity HFpEF Phenotype

Kosiborod, M. N., Abildstrøm, S. Z., Borlaug, B. A., Butler, J., Christensen, L., Davies, M., Hovingh, K. G., Kitzman, D. W., Lindegaard, M. L., Møller, D. V., et al. (2023) · JACC: Heart Failure

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 97

Semaglutide and NT-proBNP in Obesity-Related HFpEF

Petrie, M. C., Borlaug, B. A., Butler, J., Davies, M. J., Kitzman, D. W., Shah, S. J., Verma, S., Jensen, T. J., Einfeldt, M. N., Liisberg, K., et al. (2024) · Journal of the American College of Cardiology

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 95

Causality between non-alcoholic fatty liver disease and risk of cardiovascular disease and type 2 diabetes: a meta-analysis with bias analysis

Morrison, A. E., Zaccardi, F., Khunti, K., & Davies, M. J. (2019) · Liver International

Liver Disease Diagnosis and TreatmentDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 92

Changes in Glucose Metabolism and Glycemic Status With Once-Weekly Subcutaneous Semaglutide 2.4 mg Among Participants With Prediabetes in the STEP Program

Perreault, L., Davies, M., Frias, J. P., Laursen, P. N., Lingvay, I., Machineni, S., Varbo, A., Wilding, J. P. H., Wallenstein, S. O. R., & le Roux, C. W. (2022) · Diabetes Care

Diabetes Treatment and ManagementPharmacology and Obesity Treatment

Cited by 87

Metabolic Effects of Breaking Prolonged Sitting With Standing or Light Walking in Older South Asians and White Europeans: A Randomized Acute Study

Yates, T., Edwardson, C. L., Celis-Morales, C., Biddle, S. J. H., Bodicoat, D., Davies, M. J., Esliger, D., Henson, J., Kazi, A., Khunti, K., et al. (2020) · The Journals of Gerontology: Series A

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 87

Once-Weekly Exenatide Versus Once- or Twice-Daily Insulin Detemir

Davies, M., Heller, S., Sreenan, S., Sapin, H., Adetunji, O., Tahbaz, A., & Vora, J. (2013) · Diabetes Care

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 83

Efficacy and Tolerability of Sodium-Glucose Co-Transporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists: A Systematic Review and Network Meta-Analysis

Hussein, H., Zaccardi, F., Khunti, K., Davies, M. J., Patsko, E., Dhalwani, N. N., Kloecker, D. E., Ioannidou, E., & Gray, L. J. (2020) · Diabetes, Obesity and Metabolism

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 82

Skin autofluorescence, a non-invasive marker of advanced glycation end products: clinical relevance and limitations

Da Moura Semedo, C., Webb, M., Waller, H., Khunti, K., & Davies, M. (2017) · Postgraduate Medical Journal

Advanced Glycation End Products researchSkin Diseases and Diabetes

Cited by 81

Association of anthropometric obesity measures with chronic kidney disease risk in a non-diabetic patient population

Burton, J. O., Gray, L. J., Webb, D. R., Davies, M. J., Khunti, K., Crasto, W., Carr, S. J., & Brunskill, N. J. (2012) · Nephrology Dialysis Transplantation

Chronic Kidney Disease and DiabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 77

Wrist-worn accelerometers: recommending ~1.0 m g as the minimum clinically important difference (MCID) in daily average acceleration for inactive adults

Rowlands, A., Davies, M., Dempsey, P., Edwardson, C., Razieh, C., & Yates, T. (2021) · British Journal of Sports Medicine

Physical Activity and HealthContext-Aware Activity Recognition Systems

Cited by 74

New therapies for obesity

Papamargaritis, D., le Roux, C. W., Holst, J. J., & Davies, M. J. (2024) · Cardiovascular Research

Pharmacology and Obesity TreatmentRegulation of Appetite and Obesity

Cited by 73

Levels of physical activity and relationship with markers of diabetes and cardiovascular disease risk in 5474 white European and South Asian adults screened for type 2 diabetes

Yates, T., Davies, M. J., Gray, L. J., Webb, D., Henson, J., Gill, J. M. R., Sattar, N., & Khunti, K. (2010) · Preventive Medicine

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 70

Waking Up to the Importance of Sleep in Type 2 Diabetes Management: A Narrative Review.

Henson, J., Covenant, A., Hall, A. P., Herring, L., Rowlands, A. V., Yates, T., & Davies, M. J. (2024) · Diabetes Care

Sleep and related disordersCircadian rhythm and melatonin

Cited by 69

Waist circumference measurement: knowledge, attitudes and barriers in patients and practitioners in a multi-ethnic population

Dunkley, A. J., Stone, M. A., Patel, N., Davies, M. J., & Khunti, K. (2009) · Family Practice

Obesity and Health PracticesHealth Promotion and Cardiovascular Prevention

Cited by 60

Associations of reallocating sitting time into standing or stepping with glucose, insulin and insulin sensitivity: A cross-sectional analysis of adults at risk of type 2 diabetes

Edwardson, C. L., Henson, J., Bodicoat, D. H., Bakrania, K., Khunti, K., Davies, M. J., & Yates, T. (2017) · BMJ Open

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 59

Rationale, design and baseline data from the Pre-diabetes Risk Education and Physical Activity Recommendation and Encouragement (PREPARE) programme study: A randomized controlled trial

Yates, T., Davies, M., Gorely, T., Bull, F., & Khunti, K. (2008) · Patient Education and Counseling

Physical Activity and HealthDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 58